Bessemer Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
71
| – | – | ﹤0.01% | 2325 |
|
|
2025
Q1 | $1K | Buy |
+71
| New | +$1K | ﹤0.01% | 2362 |
|
|
2024
Q2 | – | Sell |
-17,390
| Closed | -$272K | – | 2110 |
|
|
2024
Q1 | $272K | Hold |
17,390
| – | – | ﹤0.01% | 945 |
|
|
2023
Q4 | $260K | Hold |
17,390
| – | – | ﹤0.01% | 979 |
|
|
2023
Q3 | $281K | Hold |
17,390
| – | – | ﹤0.01% | 954 |
|
|
2023
Q2 | $722K | Hold |
17,390
| – | – | ﹤0.01% | 704 |
|
|
2023
Q1 | $1.05M | Hold |
17,390
| – | – | ﹤0.01% | 577 |
|
|
2022
Q4 | $1.28M | Hold |
17,390
| – | – | ﹤0.01% | 532 |
|
|
2022
Q3 | $1.32M | Hold |
17,390
| – | – | ﹤0.01% | 532 |
|
|
2022
Q2 | $1.21M | Hold |
17,390
| – | – | ﹤0.01% | 535 |
|
|
2022
Q1 | $1.44M | Hold |
17,390
| – | – | ﹤0.01% | 416 |
|
|
2021
Q4 | $1.31M | Buy |
+17,390
| New | +$1.31M | ﹤0.01% | 417 |
|